Overview Allergic Rhinitis Changes the Sinus Microbiome Status: Completed Trial end date: 2014-06-01 Target enrollment: Participant gender: Summary The investigators hypothesize that treatment with QNASL will reduce nasal mucosal inflammation induced by the allergy season and prevent the changes in the microbiome caused by the allergy season. Phase: Phase 4 Details Lead Sponsor: University of Chicago